Liaison Group / The FDA / FDA’s / GE / Genetic Use Restriction Technologies / /
Continent
Antarctica / /
Country
Russia / United States / Panama / Canada / Portugal / United Kingdom / Ireland / /
Event
Product Issues / M&A / Extinction / Person Communication and Meetings / /
Facility
PEI facility / /
IndustryTerm
retail sale / biotechnology / land-based closed containment systems / biotechnology-based switch mechanisms / final product / law enforcement investigations / food security / positive applications / use restriction technologies / /
NaturalFeature
Gulf of Maine Distinct Population Segment / Inner Bay / Oceans Act.24 / Edward Island / North Atlantic islands / Bay of Fundy / Sacramento River / Hudson River / North Atlantic Ocean / Cape Cod / Oceans Canada / Snake River / Gulf of Maine / /
Organization
National Marine Fisheries Service / Council on Environmental Quality / NASCO Council / World Trade Organization / U.S. Government Accountability Office / International Salmon Farmers Association / Committee on the Status of Endangered Wildlife in Canada / United Nations Food and Agriculture Organisation / Fish and Wildlife Service / North American Commission / United States government / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / Government of Canada / Federal Government / North Atlantic Salmon Conservation Organization / FDA / European Union / GeneWatch UK / /
Person
Act / /
Position
President / Secretary of State and the Secretary of the Treasury / General / Secretary / Secretary of State / Prince / Major / Basin Head / /
Product
physical containment / basis / /
ProvinceOrState
Maine / Prince Edward Island / Oregon / Washington / California / Idaho / /
Region
North Atlantic / eastern Maine / /
Technology
biotechnology / ESA / use restriction technologies / /
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0899] GeneWatch UK comments on: Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning